Subscribe for great stories in your community!
Plymouth Meeting-based Inovio Pharmaceuticals is expecting to raise $36 million through a stock offering this week, writes John George for the Philadelphia Business Journal…
Plymouth Meeting’s Inovio Pharmaceuticals is getting closer to seeking U.S. Food & Drug Administration approval for its first DNA medicine, writes John George…
Plymouth Meeting-based Inovio Pharmaceuticals is on the right track to launch its first product which would also be the first DNA medicine in the…
Inovio Pharmaceuticals in Plymouth Meeting continues to trim its workforce. In this third round of layoffs in 13 months, the pharmaceutical company eliminated 30% of…
Plymouth Meeting-based Inovio has replaced co-founder J. Joseph Kim as CEO and announced that it will shift its focus from developing a COVID…
Inovio Pharmaceuticals spinoff Geneos Therapeutics, a Plymouth Meeting clinical stage biotherapeutics company, has raised $17 million in a private stock sale to expand its cancer…
Plymouth Meeting-based Inovio is adopting a new strategy in the hopes of gaining regulatory approval for its COVID-19 vaccine candidate, INO-4800, writes…
Plymouth Meeting-based Inovio Pharmaceuticals has expanded the late-stage testing of its COVID-19 vaccine candidate it is working on with China’s Advaccine…
Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided to pull its…
Plymouth Meeting-based Inovio saw its stock jump after signing a collaboration and license agreement with Advaccine Biopharmaceuticals Suzhou for its COVID-19 DNA vaccine…
Geneos Therapeutics, the cancer immunotherapy startup that is a spinoff of Plymouth Meeting-based Inovio, has managed to raise $10.4 million in a private…
Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its COVID-19 vaccine candidate…
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze for the Yahoo…
A growing number of local pharmaceutical, biotech, and medical device companies are joining efforts to develop a COVID-19 vaccine, writes John George for the…
While many companies in the Philadelphia region have seen their share price decimated during the coronavirus pandemic, conversely Plymouth Meeting-based Inovio Pharmaceuticals has seen…
Drug companies and university scientists across the world are working around the clock to find a vaccine against COVID-19 and Plymouth Meeting-based Inovio…
As the search for the coronavirus vaccine continues, several local companies are at the heart of this crucially important process, writes Joseph N. DiStefano for…
Starting on Monday, an experimental COVID-19 vaccine created by Plymouth Meeting-based Inovio Pharmaceuticals has been administered to three Philadelphia volunteers, writes Tom Avril…
Before we send you to this site, please subscribe to our daily newsletter.